Publication: PharmaBiz

First reported 19 hours ago - Updated 19 hours ago - 1 reports

OncoGenex to begin Cedar trial evaluating OGX-427 in combo with chemotherapy in advanced squamous cell lung cancer

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company,has planned to initiate the Cedar clinical trial, an investigator-sponsored, randomized, open-label phase II trial evaluating OGX-427 in previously untreated patients with advanced squamous ... [Published PharmaBiz - 19 hours ago]

Entities: OGX-427, OncoGenex Pharmaceuticals, Lung Cancer

First reported 21 hours ago - Updated 21 hours ago - 1 reports

NOVO NORDISK A/S

Novo Nordisk phase III a obesity trial with liraglutide 3 mg confirms weight loss

Novo Nordisk, a global healthcare company, has reported headline results from a 56-week double-blind phase III a clinical trial investigating the potential of liraglutide to induce and maintain weight loss in people without diabetes who are obese or overweight ... [Published PharmaBiz - 21 hours ago]

Entities: Obesity, Weight Loss, Placebo, NOVO NORDISK A/S

First reported 22 hours ago - Updated 22 hours ago - 1 reports

Empire Genomics buys DNA biomarker license from Cornell Univ for diagnostic test to treat patients with NEPC

Empire Genomics (EG), a molecular diagnostics company, has acquired an exclusive license for a patent pending novel genomic biomarker from Cornell University for use in developing a molecular diagnostic test that could help in diagnosing and determining ... [Published PharmaBiz - 22 hours ago]

Entities: Genomics, Biomarker, Prostate Cancer, Patient, neuroendocrine

First reported 23 hours ago - Updated 23 hours ago - 1 reports

FDA Food & Drug Administration

US FDA allows marketing of Roche's Tina-quant HbA1cDx assay test for diagnosing diabetes

The US Food and Drug Administration (FDA) has allowed marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay (Tina-quant HbA1cDx assay) for the diagnosis of diabetes by health care professionals. This is the first HbA1c test that FDA has allowed ... [Published PharmaBiz - 23 hours ago]

Entities: Diabetes, Assay, FDA Food & Drug Administration, Hemoglobin

First reported May 25 2013 - Updated May 25 2013 - 1 reports

Commerce Ministry to develop short term strategy to achieve projected pharma export target by 2015

Concerned over slow pace of growth in pharmaceutical export from India, Ministry of Commerce has decided to develop a short term strategy to boost the pharma exports and reach the projected target at least by the year 2015.After having reviewed the export ... [Published PharmaBiz - May 25 2013]

Entities: India, Ministry of Commerce

First reported May 25 2013 - Updated May 25 2013 - 1 reports

Karnataka govt to invest Rs.90 cr to set up Arogya Soudha to house all offices of health dept

Karnataka government will invest Rs.90 crore to set up an 'Aarogya Soudha' that which will be a dedicated centre housing all departments of the health and family welfare. The centre would be a nine-storey ‘green’ building for which four acres had been ... [Published PharmaBiz - May 25 2013]

Entities: Biometrics, Social Welfare, Karnataka Government, Complaints

First reported May 25 2013 - Updated May 25 2013 - 1 reports

CSIR-IICT scientist bags international innovation award

The Hyderabad based CSIR-IICT scientist Dr B L A Prabhavathi Devi, principal scientist at Centre for Lipid Research, has bagged American Oil Chemists’ Society’s ACI/NBB Glycerine Innovation Award for her outstanding research for the development of glycerol-based ... [Published PharmaBiz - May 25 2013]

Entities: Glycerine, Biodiesel, Catalyst, Invention

First reported May 25 2013 - Updated May 25 2013 - 1 reports

TeamLease annual report indicates double digit increments in pharma, healthcare sectors

TeamLease, a placement agency specialising in temporary staffing, has stated that pharmaceuticals and healthcare industry indicate double-digit increments to the employees across the board.In its annual Salary Primer (Perm & Temp) covering staff working ... [Published PharmaBiz - May 25 2013]

Entities: Health Care, Annual Report, Attrition Rate, Synchronization

First reported May 24 2013 - Updated May 24 2013 - 1 reports

Ceregene announces additional efficacy data from phase IIb study of CERE-120 to treat Parkinson's diseases

Ceregene, Inc., a biotechnology company, has reported additional efficacy data from a secondary analysis of its double-blind, randomized, controlled phase IIb clinical study of CERE- 120 (AAV-neurturin). CERE-120 is a gene therapy product designed to ... [Published PharmaBiz - May 24 2013]

Entities: Ceregene Inc, Parkinson's Disease, Neuron, Gene Therapy

First reported May 24 2013 - Updated May 24 2013 - 1 reports

Arjuna Natural Extracts subsidiary, Curegarden offers patented BCM -95 for inflammatory diseases

Curegarden, a subsidiary of Arjuna Natural Extracts Ltd (ANEL), has launched a patented ingredient BCM-95, a 100 per cent standardized extract of Turmeric’s most active compound.BCM- 95 has five US patents and one from Japan. The enhanced bioavailability ... [Published PharmaBiz - May 24 2013]

Entities: Patent, Diabetes, curcumin, Bangalore, Turmeric

First reported May 24 2013 - Updated May 24 2013 - 1 reports

Prosonix begins phase II study with PSX1002 in patients with moderate to severe COPD

Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, has started a phase II clinical study with PSX1002 that will assess its effect on lung function and the safety of a range of doses ... [Published PharmaBiz - May 24 2013]

Entities: Chronic Obstructive Pulmonary Disease, Patient, Glycopyrronium

First reported May 24 2013 - Updated May 24 2013 - 1 reports

XCyton wins India Innovation Growth Programme 2013 award for its molecular diagnostic platform SES

XCyton Diagnostics has bagged the DST Lockheed Martin India Innovation Growth Programme 2013 award for its molecular diagnostic platform ‘Syndrome Evaluation System’ (SES).SES is a single test for the simultaneous detection of all the probable causative ... [Published PharmaBiz - May 24 2013]

Entities: Diagnostic, Federation of Indian Chambers of Commerce and I..., India, Invention, Diagnostics

Quotes

...Peter Schmid MD PhD FRCP, director of the Barts/Brighton Experimental Cancer Medicine Centre and the primary investigator on the trial. "Given the preclinical evidence demonstrating significant overexpression of Hsp27 in squamous cell lung cancers, the ability of OGX-427 to inhibit the production of this protein that is linked with resistance to chemotherapy, and the viable combination with gemcitabine and carboplatin, we are hopeful that Cedar will provide meaningful data on the potential of OGX-427 to improve survival outcomes in this difficult-to-treat population."

OncoGenex to begin Cedar trial evaluating OGX-427 in combo with chemotherapy in advanced squamous ... [Published PharmaBiz - 19 hours ago]

...are very pleased to work with Drs Rubin and Beltran and Cornell to commercialize this technology," said Anthony Johnson , CEO of Empire Genomics. "It is another exciting genomic tool that we have added to our exclusive precision medicine portfolio."

Empire Genomics buys DNA biomarker license from Cornell Univ for diagnostic test to treat patient ... [Published PharmaBiz - 22 hours ago]

...would be a nine-storey ‘green building for which four acres had been identified and its foundation stone was expected to be laid within a week. "This initiative would enhance efficiency of the department and promote teamwork" said the state health and family welfare minister

Karnataka govt to invest Rs.90 cr to set up Arogya Soudha to house all offices of health dept [Published PharmaBiz - May 25 2013]

...The title of Dr Bartus' talk was: "CERE-120 (AAV2- neurturin) for the treatment of Parkinson's disease: Experience from 4 clinical trials and human autopsy data"

Ceregene announces additional efficacy data from phase IIb study of CERE-120 to treat Parkinson's ... [Published PharmaBiz - May 24 2013]

More Content

sort by: Date \| Relevance
OncoGenex to begin Cedar trial evaluating OGX-4... [Published PharmaBiz - 19 hours ago]
Novo Nordisk phase III a obesity trial with lir... [Published PharmaBiz - 21 hours ago]
Empire Genomics buys DNA biomarker license from... [Published PharmaBiz - 22 hours ago]
US FDA allows marketing of Roche's Tina-quant H... [Published PharmaBiz - 23 hours ago]
Commerce Ministry to develop short term strateg... [Published PharmaBiz - May 25 2013]
Karnataka govt to invest Rs.90 cr to set up Aro... [Published PharmaBiz - May 25 2013]
TeamLease annual report indicates double digit ... [Published PharmaBiz - May 25 2013]
CSIR-IICT scientist bags international innovati... [Published PharmaBiz - May 25 2013]
Ceregene announces additional efficacy data fro... [Published PharmaBiz - May 24 2013]
XCyton wins India Innovation Growth Programme 2... [Published PharmaBiz - May 24 2013]
Prosonix begins phase II study with PSX1002 in ... [Published PharmaBiz - May 24 2013]
Arjuna Natural Extracts subsidiary, Curegarden ... [Published PharmaBiz - May 24 2013]
Par Pharma begins shipment of candesartan cilex... [Published PharmaBiz - May 24 2013]
Singh family terms allegations by Daiichi Sanky... [Published PharmaBiz - May 24 2013]
IDMA opposes 45 days time set by DoP for cleari... [Published PharmaBiz - May 24 2013]
DBT launches programme to enhance capacity, cap... [Published PharmaBiz - May 24 2013]
DPT says many HCs reject demands to have qualif... [Published PharmaBiz - May 24 2013]
APDCA embarks to digital mode for issuing licen... [Published PharmaBiz - May 24 2013]
MSCDA wants govt to develop training module foc... [Published PharmaBiz - May 24 2013]
IFPMA launches âDo You Mind?â campaign to focus... [Published PharmaBiz - May 23 2013]
Janssen publishes primary efficacy, safety resu... [Published PharmaBiz - May 23 2013]
Daiichi Sankyo plans legal steps against former... [Published PharmaBiz - May 23 2013]
Only two out six new NIPERS get land for buildi... [Published PharmaBiz - May 23 2013]
Lack of rules for herb collection, transportati... [Published PharmaBiz - May 23 2013]
Guj FDCA busts racket in Ahmedabad selling spur... [Published PharmaBiz - May 23 2013]
Assns of Ayurveda docs send proposals for new h... [Published PharmaBiz - May 23 2013]
R-Tech Ueno begins patient enrollment in phase ... [Published PharmaBiz - May 22 2013]
Ranbaxy taking steps to improve quality assuran... [Published PharmaBiz - May 22 2013]
Quintiles rated as leader among CROs in service... [Published PharmaBiz - May 22 2013]
Acorda gets additional US patent for Ampyra cov... [Published PharmaBiz - May 22 2013]